Market closed
Vigil Neuroscience, Inc./$VIGL
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Vigil Neuroscience, Inc.
Vigil Neuroscience Inc is a clinical-stage biotechnology company engaged in improving the lives of patients, caregivers, and families affected by rare and common neurodegenerative diseases by pursuing the development of disease-modifying therapeutics to restore the vigilance of microglia. Microglia are the sentinel immune cells of the brain and play a critical role in maintaining central nervous system (CNS) health and responding to damage caused by disease. The group provides solutions for fully human monoclonal antibody and Oral small molecule TERM2 agonist.
Ticker
$VIGL
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
69
Website
VIGL Metrics
BasicAdvanced
$73M
-
-$2.07
1.84
-
Price and volume
Market cap
$73M
Beta
1.84
52-week high
$2.75
52-week low
$1.52
Financial strength
Current ratio
2.946
Quick ratio
2.881
Long term debt to equity
16.625
Total debt to equity
18.071
Management effectiveness
Return on assets (TTM)
-43.36%
Return on equity (TTM)
-89.69%
Valuation
Price to book
0.89
Price to tangible book (TTM)
0.89
Price to free cash flow (TTM)
-1.238
Growth
Earnings per share change (TTM)
-2.95%
3-year earnings per share growth (CAGR)
-58.15%
VIGL News
AllArticlesVideos
Vigil Neuroscience Presents Data on its Small Molecule TREM2 Agonist VG-3927 in Two Oral Presentations at AD/PD™ 2025 International Conference
GlobeNewsWire·4 days ago
Vigil Neuroscience Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Recent Business Updates
GlobeNewsWire·3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Vigil Neuroscience, Inc. stock?
Vigil Neuroscience, Inc. (VIGL) has a market cap of $73M as of April 06, 2025.
What is the P/E ratio for Vigil Neuroscience, Inc. stock?
The price to earnings (P/E) ratio for Vigil Neuroscience, Inc. (VIGL) stock is 0 as of April 06, 2025.
Does Vigil Neuroscience, Inc. stock pay dividends?
No, Vigil Neuroscience, Inc. (VIGL) stock does not pay dividends to its shareholders as of April 06, 2025.
When is the next Vigil Neuroscience, Inc. dividend payment date?
Vigil Neuroscience, Inc. (VIGL) stock does not pay dividends to its shareholders.
What is the beta indicator for Vigil Neuroscience, Inc.?
Vigil Neuroscience, Inc. (VIGL) has a beta rating of 1.84. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.